ScoreWhy is COFCO Biotechnology Co., Ltd. ?
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -4.55% and Operating profit at -166.84% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 4.87% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -4.55% and Operating profit at -166.84% over the last 5 years
3
With a fall in Net Profit of -1173.18%, the company declared Very Negative results in Mar 26
- The company has declared negative results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at CNY 1,172.05 MM
- INTEREST(Q) At CNY 19.38 MM has Grown at 75.35%
- RAW MATERIAL COST(Y) Grown by 21.63% (YoY)
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -23.37%, its profits have fallen by -242.5%
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -23.37% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is COFCO Biotechnology Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
COFCO Biotechnology Co., Ltd.
-8.77%
-0.84
29.24%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-4.55%
EBIT Growth (5y)
-166.84%
EBIT to Interest (avg)
2.17
Debt to EBITDA (avg)
175.06
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
1.31
Tax Ratio
26.91%
Dividend Payout Ratio
144.93%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.71%
ROE (avg)
4.87%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.79
EV to EBIT
-65.57
EV to EBITDA
37.55
EV to Capital Employed
0.81
EV to Sales
0.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.24%
ROE (Latest)
-0.93%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-23What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 180.38 MM
PRE-TAX PROFIT(Q)
At CNY -52.9 MM has Fallen at -179.75%
NET PROFIT(Q)
At CNY -49.39 MM has Fallen at -96.08%
NET SALES(9M)
At CNY 12,444.23 MM has Grown at -9.44%
ROCE(HY)
Lowest at -2.27%
RAW MATERIAL COST(Y)
Grown by 66.03% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 9.92 times
Here's what is not working for COFCO Biotechnology Co., Ltd.
Pre-Tax Profit
At CNY -52.9 MM has Fallen at -179.75%
over average net sales of the previous four periods of CNY -18.91 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -49.39 MM has Fallen at -96.08%
over average net sales of the previous four periods of CNY -25.19 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Operating Cash Flow
Lowest at CNY 180.38 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Net Sales
At CNY 12,444.23 MM has Grown at -9.44%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Debtors Turnover Ratio
Lowest at 9.92 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 66.03% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
